SCHEMBL17876178

SCHEMBL17876178

CC1(C)Oc2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)ccc2-c2cc(-c3cc(-c4cccnc4)cc(-c4cccnc4)c3)ccc2O1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.48
CYP11B1 P15538 7/20 0.41
CYP11B2 P19099 7/20 0.41
BACE1 P56817 3/20 0.41
KCNH2 Q12809 1/20 0.41
PDK2 Q15119 2/20 0.41
CYP17A1 P05093 2/20 0.39
CTSD P07339 1/20 0.39
DHODH Q02127 1/20 0.38
GAA P10253 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GLA P06280 1/20 0.37
FGFR1 P11362 1/20 0.36
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PGR P06401 1/20 0.35
TNKS O95271 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876175 1.00 CYP19A1 (0.48) CYP19A1CYP11B1CYP11B2BACE1KCNH2
SCHEMBL17876214 0.96 CYP19A1 (0.52) CYP19A1CYP11B1CYP11B2BACE1KCNH2
SCHEMBL17876162 0.92 CYP11B1 (0.46) CYP19A1CYP11B1CYP11B2BACE1KCNH2
SCHEMBL17876161 0.92 CYP11B1 (0.46) CYP19A1CYP11B1CYP11B2BACE1KCNH2
SCHEMBL17876173 0.91 CYP11B1 (0.49) CYP19A1CYP11B1CYP11B2BACE1KCNH2
SCHEMBL17876179 0.90 KMT2A (0.39) CYP19A1BACE1PDK2CTSDGAA
SCHEMBL17876165 0.90 KMT2A (0.39) CYP19A1BACE1PDK2CTSDGAA
SCHEMBL17876176 0.90 MAPT (0.38) CYP19A1BACE1CTSDGAAKDM4E
SCHEMBL17876211 0.87 BACE1 (0.48) CYP19A1CYP11B1CYP11B2BACE1KCNH2
SCHEMBL17876213 0.86 CYP11B1 (0.50) CYP19A1CYP11B1CYP11B2BACE1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP19A1 167/4885CYP11B1 938/4885CYP11B2 1374/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP19A1 167/4885CYP11B1 938/4885CYP11B2 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.